Skip to main content
SpringerLink
Log in

Nonhereditary heterotopic ossification Implications for Injury, Arthropathy, and Aging

  • Fibrodysplasia Ossificans Progressiva
  • Published:
Clinical Reviews in Bone and Mineral Metabolism Aims and scope Submit manuscript

Abstract

Nonhereditary heterotopic ossification (NHHO) usually arises in the setting of trauma, certain arthropathies, or following injury, often in the setting of common age-related conditions. In this article, we discuss the pathophysiology, diagnosis, and clinical findings in periarticular NHHO and the relevance to age-related pathology, as well as the prevention and treatment of NHHO. Except for the precipitating events or clinical conditions in which NHHO occurs, primary etiological mechanisms remain unknown. Many forms of NHHO develop in the context of injury and inflammation, suggesting that the formation of extraskeletal bone may share similar initiating events with ectopic ossification in fibrodysplasia ossificans progressiva.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Neal B, Gray H, MacMahon S, Dunn L. 2002 Incidence of heterotopic bone formation after major hipsurgery. ANZ J. Surg 72:808–821.

    Article  PubMed  Google Scholar 

  2. Garland DE, Blum CE, Waters RL. 1980 Periarticular heterotopic ossification in head-injured adults. Incidence and location. J Bone Joint Surg Am 62:1143–1146.

    PubMed  CAS  Google Scholar 

  3. Mohler ER 3rd, Gannon F, Reynolds C, Zimmerman, R, Keane MG, Kaplan FS. 2001 Bone formation and inflammation in cardiac valves. Circulation 103:1522–1528.

    PubMed  Google Scholar 

  4. Chan ED, Morales DV, Welsh CH, McDermott MT, Schwarz, MI. 2002 Calcium deposition with or without bone formation in the lung. Am J Resp Crit Care Med 165:1654–1669.

    Article  PubMed  Google Scholar 

  5. Ackerman LV. 1958 Extra-osseous localized non-neoplastic bone and cartilage formation (so-called myositis, ossificans): clinical and pathological confusion with malignant neoplasms. J Bone Joint Surg Am 40-A:279–298.

    PubMed  CAS  Google Scholar 

  6. Watson KE, Bostrom K, Ravindranath R, Lam T, Norton B, Demer LL. 1994 TGF-beta 1 and 25-hydroxycholesterol stimulate osteoblast-like vascular cells to calcify. J Clin Invest 93:2106–2113.

    Article  PubMed  CAS  Google Scholar 

  7. Mohler ER 3rd, Chawla MK, Chang AW, et al. 1999 Identification and characterization of calcifying valve cells from human and canine aortic valves. J Heart Valve Dis 8: 254–260.

    PubMed  Google Scholar 

  8. Bidner SM, Rubins IM, Desjardins JV, Zukor DJ, Goltzman D. 1990 Evidence for a humoral mechanism for enhanced osteogenesis after head injury. J Bone Joint Surg Am 72:1144–1149.

    PubMed  CAS  Google Scholar 

  9. Kurer MH, Khoker MA, Dandona P. 1992 Human osteoblast stimulation by sera from paraplegic patients with heterotopic ossification. Paraplegia 30:165–168.

    PubMed  CAS  Google Scholar 

  10. Renfree KJ, Banovac K, Hornicek FJ, Lebwohl NH, Villanueva PA, Nedd KJ. 1994 Evaluation of serum osteoblast mitogenic activity in spinal cord and head injury patients with acute heterotopic ossification. Spine 19:740–746.

    Article  PubMed  CAS  Google Scholar 

  11. Ekelund A, Brosjö O, Nilsson, OS. 1991 Experimental induction of heterotopic bone. Clin Orthop Rel Res 263: 102–112.

    Google Scholar 

  12. Kan L, Hu M, Gomes WA, Kessler JA. 2004 Transgenic mice overexpressing BMP4 develop a fibrodysplasia ossificans progressiva (FOP)-like phenotype. Am J Pathol 165:1107–1115.

    PubMed  CAS  Google Scholar 

  13. Glaser DL, Economides AN, Wang L, et al. 2003 In vivo somatic cell gene transfer of an engineered Noggin mutein prevents BMP4-induced heterotopic ossification. J Bone Joint Surg Am 85-A:2332–2342.

    PubMed  Google Scholar 

  14. Scutt A, Bertram P. 1995 Bone marrow cells are targets for the anabolic actions of prostaglandin E2 on bone: induction of a transition from nonadherent to adherent osteoblast precursors. J Bone Miner Res 10:474–487.

    Article  PubMed  CAS  Google Scholar 

  15. Schurch, B, Capaul, M, Vallottom, MB, Rossier, AB 1997 Prostaglandin E2 measurements: their value in the early diagnosis of heterotopic ossification in spinal cord injury patients. Arch Phys Med Rehabil 78:687–691.

    Article  PubMed  CAS  Google Scholar 

  16. Ceradini DJ, Kulkarni AR, Callaghan MJ, et al. 2004 Progenitor cell trafficking is regulated by hypoxic gradients through HIF-1 induction of SDF-1. Nat Med 10: 858–864.

    Article  PubMed  CAS  Google Scholar 

  17. Phillips RJ, Burdick MD, Hong K, et al. 2004 Circulating fibrocytes traffic to the lungs in response to CXCL 12 and mediate fibrosis. J Clin Invest 114:438–446.

    Article  PubMed  CAS  Google Scholar 

  18. Pignolo, RJ, Billings, PC, Suda, RK, et al. 2004 Circulating osteogenic cells in heterotopic bone formation. J Bone Min Res 19:S35.

    Google Scholar 

  19. Kaplan FS, Glaser DL, Hebela N, Shore EM. 2004 Heterotopic ossification. J Am Acad Orthop Surg 12: 116–125.

    PubMed  Google Scholar 

  20. Neal B. 2003 Effects of heterotopic bone formation on outcome after hiparthroplasty. ANZ J Surg 73:422–426.

    Article  PubMed  Google Scholar 

  21. Barrack RL, Brumfield CS, Rorabeck CH, Cleland D, Myers L. 2002 Heterotopic ossification after revision to tal knee arthroplasty. Clin Orthop 404:208–213.

    Article  PubMed  Google Scholar 

  22. Edwards JE. 1961 Calcific aortic stenosis: pathologic features. Mayo Clin Proc 36:444–451.

    PubMed  CAS  Google Scholar 

  23. Lane JE, Dean RJ, Foulkes GD, Chandler PW. 2002 Idiopathic heterotopic ossification in the intensive care setting. Postgrad Med J 78:494–495.

    Article  PubMed  CAS  Google Scholar 

  24. Neal BC, Rodgers A, Clark T, et al. 2000 A systematic survey of 13 randomized trials of non-steroidal anti-inflammatory drugs for the prevention of heterotopic bone formation after major hip surgery. Acta Orthop Scand 71: 122–128.

    Article  PubMed  CAS  Google Scholar 

  25. Banovac K. 2003 The effect of etidronate on late development of heterotopic ossification after spinal cord injury. J Spinal Cord Med. 23:40–44.

    Google Scholar 

  26. Cornes PG, Shahidi M, Glees JP. 2002 Heterotopic bone formation: irradiation of high risk patients. Br J Radiol 75: 448–452.

    PubMed  CAS  Google Scholar 

  27. Lo TC, Healy WL. 2001 Re-irradiation for prophylaxis of heterotopic ossification after hip surgery. Br J Radiol 74: 503–506.

    PubMed  CAS  Google Scholar 

  28. Gear AJ, Buckley C, Kaplan F, Vanbeek A. 2004 Multifactorial refractory heterotopic ossification. Ann Plast Surg 52:319–324.

    Article  PubMed  Google Scholar 

  29. Carabello BA. 2002 Clinical practice. Aortic stenosis. N Engl J Med 346:677–682.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Medicine, The University of Pennsylvania School of Medicine, 424 Stemmler Hall, 36th and Hamilton Walk, 19104, Philadelphia, PA

    Robert J. Pignolo MD, PhD & Kristin L. Foley DO

Authors
  1. Robert J. Pignolo MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Kristin L. Foley DO
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Robert J. Pignolo MD, PhD.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Pignolo, R.J., Foley, K.L. Nonhereditary heterotopic ossification Implications for Injury, Arthropathy, and Aging . Clinic Rev Bone Miner Metab 3, 261–266 (2005). https://doi.org/10.1385/BMM:3:3-4:261

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1385/BMM:3:3-4:261

Key Words

Search

Navigation